See also: Generic Verelan
Verelan PM is a brand name of verapamil, approved by the FDA in the following formulation(s):
VERELAN PM (verapamil hydrochloride - capsule, extended release; oral)
Manufacturer: ELAN DRUG
Approval date: November 25, 1998
Strength(s): 100MG [AB], 200MG [AB], 300MG [RLD][AB]
Has a generic version of Verelan PM been approved?
Yes. The following products are equivalent to Verelan PM:
verapamil hydrochloride capsule, extended release; oral
Manufacturer: MYLAN
Approval date: August 9, 2007
Strength(s): 100MG [AB], 200MG [AB], 300MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Verelan PM. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Verelan PM.
See also...
- Verelan PM Sustained-Release Capsules Controlled Onset Consumer Information (Wolters Kluwer)
- Verelan PM Consumer Information (Cerner Multum)
- Verelan PM Advanced Consumer Information (Micromedex)
- Verapamil Consumer Information (Drugs.com)
- Verapamil Consumer Information (Wolters Kluwer)
- Verapamil Controlled-Release Tablets Consumer Information (Wolters Kluwer)
- Verapamil Immediate-Release Consumer Information (Wolters Kluwer)
- Verapamil Immediate-Release Tablets Consumer Information (Wolters Kluwer)
- Verapamil Sustained-Release Capsules Controlled Onset Consumer Information (Wolters Kluwer)
- Verapamil Sustained-Release Pellet-Filled Capsules Consumer Information (Wolters Kluwer)
- Verapamil Sustained-Release Tablets (Controlled Onset) Consumer Information (Wolters Kluwer)
- Verapamil Consumer Information (Cerner Multum)
- Verapamil Advanced Consumer Information (Micromedex)
- Verapamil Intravenous Advanced Consumer Information (Micromedex)
- Verapamil Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment